Intranasal Cocaine and Temperature Regulation During Exercise (NCT05809453) | Clinical Trial Compass
CompletedPhase 1/2
Intranasal Cocaine and Temperature Regulation During Exercise
United States27 participantsStarted 2023-09-01
Plain-language summary
Assess the effects of intranasal cocaine on temperature regulation and whole-body sweat rate during exercise in warm environmental conditions.
Who can participate
Age range18 Years – 50 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 18 to 50 years of age
* Healthy
* Body mass index less than 31 kg/m\^2
* Speak English
* Systolic blood pressure \<140 mmHg
* Diastolic blood pressure \<90 mmHg
Exclusion Criteria:
* Subjects not in the defined age range
* Participants who have cardiac, respiratory, neurological, and/or metabolic illnesses
* Any known history of renal or hepatic insufficiency/disease
* Pregnancy or breast feeding
* Body mass less than 60 kilograms
* Current smokers, as well as individuals who regularly smoked within the past 3 years
* Individuals with a history of drug abuse within the past 5 years
* Individuals who have an unexplained positive urine drug screen (e.g., some agents cause false-positive results and when agent abstained the drug screen is negative, one example could be an over the counter supplement)
* Currently taking pain modifying medications
What they're measuring
1
Change in Core Temperature
Timeframe: Core temperature is measured at baseline and at 60 minutes of heat exposure.
Trial details
NCT IDNCT05809453
SponsorUniversity of Texas Southwestern Medical Center